Dental Bone Graft Substitutes Market Size, Share & COVID19 Impact Analysis | Global | 2021-2027 | 10 MedSuites | Includes: Allografts, Xenografts, Synthetic Bone Grafts, Dental Barrier Membranes & Dental Growth Factor Devices
- Year: 2021
- Scope: 10 Years
- Region: Global
- Published Date: 03/26/2021
- Type: MedSuite
This Global Report Series represents iData’s entire collection of country-level reports in the Global Dental Bone Graft Substitute market. Each of these reports may be purchased as a stand-alone report, tailoring the data to your needs. The covered countries are listed below, including the report’s publication year:
- United States (2021)
- Europe (2021)
- China (2021)
- South Korea (2021)
- India (2021)
- Japan (2021)
- Australia (2021)
- Brazil (2021)
- Mexico (2021)
- Argentina (2021)
US Dental Bone Graft Substitutes Market
In 2021, the US dental bone graft substitutes (DBGS) market size is expected to reach $390 million, with the Allograft market showing the fastest growth. Despite COVID19, the US market size is expected to increase over the forecast period to exceed $540 million in 2027. Over 40% of the dental bone graft substitutes market share in the US was dominated by three main competitors – Geistlich, Zimmer Biomet, and ACE Surgical.
Dental bone graft substitutes market growth in the US will be driven by continued technological developments that allow companies to introduce new products with innovations to increase the ease of use and patient comfort. This research takes a closer look at new product launches, specifically in the innovation-rich segments like the barrier membrane market, to understand the impact on the Average Selling Prices (ASPs) and the overall market value.
Europe Dental Bone Graft Substitutes Market
In 2021, the EU dental bone graft substitutes market size is projected to reach $272 million, which is a recovery of over 30% when compared to 2020. Despite COVID19, the EU market size is expected to increase over the forecast period to exceed $372 million in 2027. Currently, over 40% of the dental bone graft substitutes market share in Europe is dominated by two main competitors – Geistlich and Botiss Biomaterials.
The growing number of GPs placing implants is driving the European market for dental bone graft substitutes forward by increasing the volume of dental implant procedures. The growing number of GPs placing implants increases the probability that a patient is informed on the importance of having a sufficient level of bone in their jaw before the procedure. Ultimately, this will result in a greater number of patient referrals to specialists for dental regenerative procedures that incorporate dental biomaterials.
Asia Pacific Dental Bone Graft Substitutes Market
In 2021, the Asia Pacific dental bone graft substitutes market size is projected to reach $295 million, which the Chinese market showing the most promising growth. Despite COVID19, the Asia Pacific market size is expected to increase over the forecast period to exceed $667 million in 2027.
An ongoing trend within the South Korean and Indian markets for dental bone graft substitutes is the increasing market share of dental barrier membranes. In these markets, dental barrier membranes have yet to achieve similar market penetration as other developed dental markets, such as the United States. Given the high rate of dental implants placed in South Korea and India, the dental barrier membrane market is poised to experience significant growth over the forecast period.
In the Japan and Australian markets, a major limiter preventing market growth in the dental bone graft substitute and other biomaterials market is the strict regulatory environment. This largely limits competition and the products available to these markets. As a result of limited products, patients may instead opt to travel to other regions of the world to undergo a DBGS procedure.
Latin America Dental Bone Graft Substitutes Market
In 2021, the Latin America dental bone graft substitutes market size is projected to reach $72 million, which the Brazilian market showing the most promising growth. Despite COVID19, the Latin American market size is expected to increase over the forecast period to exceed $161 million in 2027.
The Mexican dental bone graft substitute market growth will be driven by continued technological developments that allow companies to introduce new products with innovations to increase the ease of use and patient comfort. New product launches have the effect of expanding a company’s product mix and capture more of the market while maintaining a steady or growing ASP in innovation-rich segments like the barrier membrane market, leading to a higher market value overall.
In the Argentinian market, dental professionals have made attempts to reduce the risk of contamination and spread of disease in bone grafting procedures. As tissue banks have gained complete control of the allograft market, they have been able to set certain rules and standards regarding these products. In hopes of reducing the spread of disease through implantation treatments, tissue banks have implemented intense laws and regulations in the use of allograft materials that prevent retailers from selling them on the market.
Global Dental Bone Graft Substitutes Market Share Insights
Geistlich is a clear leader in the dental bone graft substitutes market, particularly in Europe, where they command more than one-third of the market share themselves. The U.S. market sees stronger competition from Zimmer Biomet, ACE Surgical, and BioHorizons to compete as leaders in this space. Geistlich’s emerging market share in the overall market is a direct result of their dominance strictly within the xenograft market. The Bio-Oss® bovine xenograft product line in the xenograft realm of DBGS is recognized as the gold standard within the xenograft market. In fact, the product is the clear leader of the xenograft market.
Combining the dental divisions of each company, Zimmer Dental and BIOMET 3i merged in June of 2015, creating an entity that rivals that of Geistlich in the United States. The company continues to maintain a strong presence in the overall DBGS market by providing products in the mineralized allograft, DBM allograft, xenograft, and synthetic sub-segments of the market. In the European market, Zimmer Biomet still trails behind Botiss Biomaterials.
Botiss continues to experience significant growth, largely owing to its distribution deal established with Straumann, a leading dental implant manufacturer. The company is headquartered in Berlin, Germany and has R&D and production sites in Germany, Austria and the United Kingdom. Unlike Geistlich, the leading competitor in the market, Botiss maintains a much more varied product portfolio in the dental biomaterial market. Though the company is most successful in the xenograft segment, Botiss also produces and distributes allograft and synthetic DBGS materials.
Global Dental Bone Graft Substitutes Market Segmentation
While this Global Series contains all global dental bone graft substitutes market data, each of the market segments is also available as a stand-alone report, MedCore. This allows you to get access to only the dental bone graft substitutes market research that you need.
- Dental Bone Grafting Procedure Numbers | US | 2021-2027 | MedPro – Using a number of databases, internal and external, we’re able to provide the volume of dental bone grafting procedures being performed in the US, including dental implant and periodontal procedures performed using bone graft substitutes.
- Dental Bone Graft Substitute Market | US, EU15*, Asia Pacific*, Latin America* | 2021-2027 | MedCore – The market analysis is further broken down into segments, such as Mineralized Allografts, Demineralized Bone Matrix (DBM) Allografts, Xenografts, and Synthetic Bone Grafts.
- Dental Barrier Membrane Market | US, EU15*, Asia Pacific*, Latin America* | 2021-2027 | MedCore – The chapter contains the market analysis which is categorized by:
- Device Type: Resorbable and Non-Resorbable Dental Barrier Membranes;
- Material Type: Xenograft, Synthetic, and Allograft.
- Dental Growth Factor Market | US, EU15*, Latin America | 2021-2027 | MedCore – The market analysis is also further segmented by:
- Device Type: Emdogain®, GEM 21S®, Infuse™, and Osteocel® devices.
*Limited Coverage Available. Please consult the respective reports for more information.
Research Scope Summary
|Regions||United States, EU15, Asia Pacific (South Korea, China, India, Japan, Australia), Latin America (Brazil, Mexico, Argentina)|
|Base Year||2020 – United States, Asia Pacific, Latin America
2019 – Europe
|Forecast||2021-2027 – United States, Asia Pacific, Latin America
2019-2025 – Europe
|Historical Data||2017-2020 – United States, Asia Pacific, Latin America
2015-2018 – Europe
|Quantitative Coverage||Market Size, Market Shares, Market Forecasts, Market Growth Rates, Units Sold, and Average Selling Prices.|
|Qualitative Coverage||COVID19 Impact, Market Growth Trends, Market Limiters, Competitive Analysis & SWOT for Top Competitors, Mergers & Acquisitions, Company Profiles, Product Portfolios, FDA Recalls, Disruptive Technologies, Disease Overviews.|
|Data Sources||Primary Interviews with Industry Leaders, Government Physician Data, Regulatory Data, Hospital Private Data, Import & Export Data, iData Research Internal Database.|
Top Dental Bone Graft Substitute Companies Analyzed
US DENTAL BONE GRAFT SUBSTITUTE MARKETTABLE OF CONTENTS ILIST OF FIGURES VIILIST OF CHARTS XEXECUTIVE SUMMARY 1U.S. DENTAL BONE GRAFT SUBSTITUTE AND OTHER BIOMATERIALS MARKET OVERVIEW 1COMPETITIVE ANALYSIS 3MARKET TRENDS 5MARKET DEVELOPMENTS 6MARKETS INCLUDED 7KEY REPORT UPDATES 8VERSION HISTORY 8RESEARCH METHODOLOGY 9Step 1: Project Initiation & Team Selection 9Step 2: Prepare Data Systems and Perform Secondary Research 12Step 3: Preparation for Interviews & Questionnaire Design 14Step 4: Performing Primary Research 15Step 5: Research Analysis: Establishing Baseline Estimates 17Step 6: Market Forecast and Analysis 18Step 7: Identify Strategic Opportunities 20Step 8: Final Review and Market Release 21Step 9: Customer Feedback and Market Monitoring 22
IMPACT OF COVID-19 ON THE U.S. DENTAL BONE GRAFT SUBSTITUTE AND OTHER BIOMATERIALS MARKET2.1 INTRODUCTION 232.2 MULTI-SCENARIO ANALYSIS 252.2.1.1 Best Case Scenario 252.2.1.2 Base Case Scenario 222.214.171.124 Worst Case Scenario 27
DISEASE OVERVIEW3.1 BASIC ANATOMY 293.1.1 Dental Anatomy: Oral Cavity and Intraoral Landmarks 293.2 DISEASE PATHOLOGY AND DISORDERS 303.2.1 General Diagnostics 303.2.2 Indication for Dental Implant 303.2.3 Periodontal Disease 313.2.4 Dental Implant Procedures 323.2.5 Guided Bone Regeneration 333.3 PATIENT DEMOGRAPHICS 343.3.1 General Dental Statistics 343.3.2 Tooth Loss Statistics 35
PRODUCT ASSESSMENT4.1 INTRODUCTION 374.2 PRODUCT PORTFOLIOS 374.2.1 Dental Bone Graft Substitutes 3126.96.36.199 Allografts 3188.8.131.52.1 Mineralized Allografts 3184.108.40.206.2 Demineralized Bone Matrix 3220.127.116.11 Autografts 318.104.22.168 Synthetics 404.2.1.4 Xenografts 414.2.2 Dental Growth Factors 444.2.3 Dental Barrier Membrane 454.3 REGULATORY ISSUES AND RECALLS 474.3.1 Geistlich 474.4 CLINICAL TRIALS 484.4.1 Dental Grafts 48
U.S. DENTAL BONE GRAFT SUBSTITUTE AND OTHER BIOMATERIALS MARKET OVERVIEW5.1 INTRODUCTION 515.1.1 Applications of Dental Bone Graft Substitutes 522.214.171.124 Dental Implant Procedures 5126.96.36.199 Periodontal Procedures 525.1.2 Types of Dental Bone Graft Substitutes 5188.8.131.52 Autografts 5184.108.40.206 Allografts 5220.127.116.11 Demineralized Bone Matrix Allografts 518.104.22.168 Xenografts 522.214.171.124 Synthetics 545.1.3 Dental Growth Factor Products 555.1.4 Dental Membranes 555.1.5 Market Penetration and End Users 565.2 MARKET OVERVIEW 575.3 TREND ANALYSIS BY SEGMENT 635.4 DRIVERS AND LIMITERS 665.4.1 Market Drivers 665.4.2 Market Limiters 685.5 COMPETITIVE MARKET SHARE ANALYSIS 715.6 MERGERS AND ACQUISITIONS 795.7 COMPANY PROFILES 815.7.1 ACE Surgical 815.7.2 BioHorizons 825.7.3 Dentsply Sirona 835.7.4 Geistlich 845.7.5 LifeNet Health 855.7.6 Medtronic 865.7.7 Osteogenics Biomedical 875.7.8 Zimmer Biomet 885.8 SWOT ANALYSIS 895.8.1 ACE Surgical 905.8.2 BioHorizons 915.8.4 Dentsply Sirona 925.8.5 Geistlich 935.8.6 LifeNet Health 945.8.7 Medtronic 955.8.8 Osteogenics Biomedical 965.8.9 Zimmer Biomet 97
PROCEDURE NUMBERS6.1 INTRODUCTION 986.2 DENTAL BONE GRAFTING PROCEDURES 99
DENTAL BONE GRAFT SUBSTITUTE MARKET7.1 INTRODUCTION 1057.1.1 Autografts 1057.1.2 Allografts 1067.1.2.1 Mineralized Allografts 1067.1.2.2 Demineralized Bone Matrix 1077.1.3 Xenografts 1077.1.4 Synthetics 1087.2 MARKET OVERVIEW 1097.3 MARKET ANALYSIS AND FORECAST 1147.3.1 Total Dental Bone Graft Substitute Market 1147.3.2 Total Allograft Market 1126.96.36.199 Mineralized Allograft Market 1188.8.131.52 Demineralized Bone Matrix Allograft Market 1257.3.3 Xenograft Market 1277.3.4 Synthetic Bone Graft Market 1307.4 UNIT ANALYSIS 1327.4.1 Bone Graft Substitute Unit Sales by Type 1327.5 DRIVERS AND LIMITERS 1357.5.1 Market Drivers 1357.5.2 Market Limiters 1377.6 COMPETITIVE MARKET SHARE ANALYSIS 140
DENTAL GROWTH FACTOR MARKET8.1 INTRODUCTION 1468.2 MARKET OVERVIEW 1478.3 MARKET ANALYSIS AND FORECAST 1518.3.1 Emdogain® Market 1518.3.2 GEM 21S® Market 1548.3.3 Infuse® Market 1578.3.4 Osteocel® Market 1608.4 DRIVERS AND LIMITERS 1638.4.1 Market Drivers 1638.4.2 Market Limiters 1648.5 COMPETITIVE MARKET SHARE ANALYSIS 167
DENTAL BARRIER MEMBRANE MARKET9.1 INTRODUCTION 1719.2 MARKET OVERVIEW 1749.3 MARKET ANALYSIS AND FORECAST 1799.3.1 Total Dental Barrier Membrane Market 1799.3.2 Resorbable Dental Barrier Membrane Market 1829.3.3 Non-Resorbable Dental Barrier Membrane Market 18184.108.40.206 Non-Reinforced Non-Resorbable Dental Barrier Membrane Market 18220.127.116.11 Titanium-Reinforced Non-Resorbable Dental Barrier Membrane Market 1919.4 UNIT ANALYSIS 1939.4.1 Dental Barrier Membrane Unit Sales by Size 1918.104.22.168 Resorbable Dental Barrier Membranes by Size 1922.214.171.124 Non-Resorbable Dental Barrier Membranes by Size 1959.4.2 Dental Barrier Membrane Unit Sales by Material 1979.5 DRIVERS AND LIMITERS 2019.5.1 Market Drivers 2019.5.2 Market Limiters 2029.6 COMPETITIVE MARKET SHARE ANALYSIS 204
Top Dental Bone Graft Substitute Companies Analyzed
iData’s 9-Step Research MethodologyOur reports follow an in-depth 9-step methodology which focuses on the following research systems:
- Original primary research that consists of the most up-to-date market data
- Strong foundation of quantitative and qualitative research
- Focused on the needs and strategic challenges of the industry participants
Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.
Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.
Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.
Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.
Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.
Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.
Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.
Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.
Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.